Although PoC PSA tests have the potentialto improve PCa diagnosisin resource-limited settings, it is unlikely that the tests presentedin Table 3 could beadopted for widespread clinical use in these environments. The gene discussed is KLK3; the disease is posterior cortical atrophy.